Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether–lumefantrine and artesunate–amodiaquine in Africa

Artemether–lumefantrine (AL) and artesunate–amodiaquine (AS-AQ) are the most commonly used artemisinin-based combination therapies (ACT) for treatment of Plasmodium falciparum in Africa. Both treatments remain efficacious, but single nucleotide polymorphisms (SNPs) in the Plasmodium falciparum multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Okell, Lucy C, Reiter, Lisa Malene, Ebbe, Lene Sandø, Baraka, Vito, Bisanzio, Donal, Watson, Oliver J, Bennett, Adam, Verity, Robert, Gething, Peter, Roper, Cally, Alifrangis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202998/
https://www.ncbi.nlm.nih.gov/pubmed/30397515
http://dx.doi.org/10.1136/bmjgh-2018-000999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202998/
https://www.ncbi.nlm.nih.gov/pubmed/30397515
http://dx.doi.org/10.1136/bmjgh-2018-000999

Ejemplares similares